Full Text Journal Articles by
Author Gregory Y H Lip

Advertisement

Find full text journal articles






Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation.

Wen-Han Cheng, Tze-Fan Chao, Yenn-Jiang Lin, Shih-Lin Chang, Li-Wei Lo, Yu-Feng Hu, Ta-Chuan Tuan, Jo-Nan Liao, Fa-Po Chung, Gregory Y H Lip, Shih-Ann Chen,

Background and Purpose- In the daily practice, low-dose nonvitamin K antagonist oral anticoagulants are commonly used among Asian patients with atrial fibrillation (AF). The aim of the present study was to compare the risks of ischemic stroke, intracranial hemorrhage, and net clinical benefit of Asian patients with AF treated with ... Read more >>

Stroke (Stroke)
[2019, :STROKEAHA119025623]

Cited: 0 times

View full text PDF listing >>



Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study.

Minjae Yoon, Pil-Sung Yang, Eunsun Jang, Hee Tae Yu, Tae-Hoon Kim, Jae-Sun Uhm, Jong-Youn Kim, Jung-Hoon Sung, Hui-Nam Pak, Moon-Hyoung Lee, Boyoung Joung, Gregory Y H Lip,

BACKGROUND: An integrated care approach might be of benefit for clinical outcomes of patients with atrial fibrillation (AF). This study evaluated whether compliance with the Atrial fibrillation Better Care (ABC) pathway for integrated care management ("A" Avoid stroke; "B" Better symptom management; "C" Cardiovascular risk and Comorbidity optimization) would improve population-based ... Read more >>

Thromb. Haemost. (Thrombosis and haemostasis)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.

Davide Capodanno, Kurt Huber, Roxana Mehran, Gregory Y H Lip, David P Faxon, Christopher B Granger, Pascal Vranckx, Renato D Lopes, Gilles Montalescot, Christopher P Cannon, Jurien Ten Berg, Bernard J Gersh, Deepak L Bhatt, Dominick J Angiolillo,

Most patients with atrial fibrillation (AF) and risk factors for stroke require oral anticoagulation (OAC) to decrease the risk of stroke or systemic embolism. This is now best achieved with direct oral anticoagulants that decrease the risk of intracranial bleeding compared with vitamin K antagonists. Of note, approximately 5% to 10% ... Read more >>

J. Am. Coll. Cardiol. (Journal of the American College of Cardiology)
[2019, 74(1):83-99]

Cited: 0 times

View full text PDF listing >>



Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease.

So-Ryoung Lee, Hyun-Jung Lee, Eue-Keun Choi, Kyung-Do Han, Jin-Hyung Jung, Myung-Jin Cha, Seil Oh, Gregory Y H Lip,

BACKGROUND:Advanced liver disease is known to increase the risk for bleeding and affects the hepatic clearance and metabolism of drugs. Subjects with active liver disease were excluded from pivotal clinical trials of direct oral anticoagulants (DOACs), so the evidence regarding the efficacy and safety of DOACs in patients with liver ... Read more >>

J. Am. Coll. Cardiol. (Journal of the American College of Cardiology)
[2019, 73(25):3295-3308]

Cited: 0 times

View full text PDF listing >>



C2 HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study.

Yan-Guang Li, Arnaud Bisson, Alexandre Bodin, Julien Herbert, Leslie Grammatico-Guillon, Boyoung Joung, Yu-Tang Wang, Gregory Y H Lip, Laurent Fauchier,

Background The C2HEST score (coronary artery disease or chronic obstructive pulmonary disease [1 point each]; hypertension [1 point]; elderly [age ≥75 years, 2 points]; systolic heart failure [2 points]; thyroid disease [hyperthyroidism, 1 point]) was initially proposed for predicting incident atrial fibrillation (AF) in the general population. Its performance in ... Read more >>

J Am Heart Assoc (Journal of the American Heart Association)
[2019, 8(13):e012546]

Cited: 0 times

View full text PDF listing >>



Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry.

Hai-Feng Liang, Xin Du, Ying-Chun Zhou, Xiao-Yi Yang, Shi-Jun Xia, Jian-Zeng Dong, Gregory Y H Lip, Chang-Sheng Ma,

BACKGROUND Several factors determine the efficacy of warfarin anticoagulation in patients with non-valvular atrial fibrillation (NVAF). This study aimed to use data from the Chinese Atrial Fibrillation Registry study to assess the control of anticoagulation therapy in Chinese patients with NVAF treated with warfarin. MATERIAL AND METHODS From the Chinese ... Read more >>

Med. Sci. Monit. (Medical science monitor : international medical journal of experimental and clinical research)
[2019, 25:4691-4698]

Cited: 0 times

View full text PDF listing >>



Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation.

So-Ryoung Lee, Tae-Min Rhee, Do-Yoon Kang, Eue-Keun Choi, Seil Oh, Gregory Y H Lip,

Guidelines recommend oral anticoagulant (OAC) monotherapy without antiplatelet therapy (APT) in patients with nonvalvular atrial fibrillation (AF) with stable coronary artery disease (CAD) of >1 year after myocardial infarction or percutaneous coronary intervention. More evidences are required for the safety and efficacy of OAC monotherapy compared with OAC plus APT. ... Read more >>

Am. J. Cardiol. (The American journal of cardiology)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Using Blood Biomarkers to Identify Atrial Fibrillation-Related Stroke.

Monika Kozieł, Tatjana S Potpara, Gregory Y H Lip,

Stroke (Stroke)
[2019, :STROKEAHA119026185]

Cited: 0 times

View full text PDF listing >>



Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.

So-Ryoung Lee, Eue-Keun Choi, Soonil Kwon, Kyung-Do Han, Jin-Hyung Jung, Myung-Jin Cha, Seil Oh, Gregory Y H Lip,

Background and Purpose- Limited evidence exists on the effectiveness and safety of warfarin and all 4 available non-vitamin K antagonist oral anticoagulants (NOACs) from current clinical practice in the Asian population with nonvalvular atrial fibrillation. We aimed to evaluate the comparative effectiveness and safety of warfarin and 4 NOACs. Methods- ... Read more >>

Stroke (Stroke)
[2019, :STROKEAHA119025536]

Cited: 0 times

View full text PDF listing >>



Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort.

Dongmin Kim, Pil-Sung Yang, Hee Tae Yu, Tae-Hoon Kim, Eunsun Jang, Jung-Hoon Sung, Hui-Nam Pak, Myung-Yong Lee, Moon-Hyoung Lee, Gregory Y H Lip, Boyoung Joung,

AIMS:Atrial fibrillation (AF) is generally regarded as a risk factor for dementia, though longitudinal studies assessing the association between AF and dementia have shown inconsistent results. This study aimed to determine the effect of AF on the risk of developing dementia using a longitudinal, community-based, and stroke-free elderly cohort. METHODS ... Read more >>

Eur. Heart J. (European heart journal)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Letter by Guo et al Regarding Article, "Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial".

Yutao Guo, Gregory Y H Lip, Tatjana Potpara,

Circulation (Circulation)
[2019, 139(24):e1037-e1038]

Cited: 0 times

View full text PDF listing >>



Response.

Gregory Y H Lip, Christian T Ruff, Lisa Moores, ,

Chest (Chest)
[2019, 155(6):1307]

Cited: 0 times

View full text PDF listing >>



Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF-App) II randomised trial.

Yutao Guo, Deirdre A Lane, Liming Wang, Yundai Chen, Gregory Y H Lip, ,

BACKGROUND:Current management of patients with atrial fibrillation (AF) is limited by low detection of AF, non-adherence to guidelines and lack of consideration of patient's preferences, thus highlighting the need for a holistic and integrated approach to AF management. This study aims to determine whether a mHealth technology-supported AF integrated management ... Read more >>

Int. J. Clin. Pract. (International journal of clinical practice)
[2019, 73(7):e13352]

Cited: 0 times

View full text PDF listing >>



Response.

Gregory Y H Lip, Christian T Ruff, Lisa Moores, ,

Chest (Chest)
[2019, 155(6):1311-1312]

Cited: 0 times

View full text PDF listing >>



β-Blocker Use in Pregnancy and the Risk for Congenital Malformations.

Alena Shantsila, D Gareth Beevers, Gregory Y H Lip,

Ann. Intern. Med. (Annals of internal medicine)
[2019, 170(12):909]

Cited: 0 times

View full text PDF listing >>



Response.

Gregory Y H Lip, Christian T Ruff, Lisa Moores, ,

Chest (Chest)
[2019, 155(6):1309]

Cited: 0 times

View full text PDF listing >>



Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices.

Daniele Pastori, Kazuo Miyazawa, Yanguang Li, Orsolya Székely, Farhan Shahid, Alessio Farcomeni, Gregory Y H Lip,

BACKGROUND:Patients with atrial high-rate episodes (AHREs) are at higher risk of thromboembolic events and mortality. The risk of major adverse cardiovascular events (MACE) in these patients is unknown. OBJECTIVE:To investigate the risk of MACE in patients implanted with cardiac implantable electronic devices (CIEDs) developing AHREs METHODS AND RESULTS: We included 852 ... Read more >>

Clin Res Cardiol (Clinical research in cardiology : official journal of the German Cardiac Society)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study.

Mette Søgaard, Flemming Skjøth, Martin Jensen, Jette Nordstrøm Kjældgaard, Gregory Y H Lip, Torben Bjerregaard Larsen, Peter Brønnum Nielsen,

Background It is unclear whether nonvitamin K antagonist oral anticoagulants ( NOAC s) can mitigate dementia development in atrial fibrillation. We compared dementia development among users of NOACs or warfarin in patients with atrial fibrillation with no prior neurological diagnoses. Methods and Results We conducted a Danish nationwide cohort study ... Read more >>

J Am Heart Assoc (Journal of the American Heart Association)
[2019, 8(11):e011358]

Cited: 0 times

View full text PDF listing >>



Revisiting the risks of incident atrial fibrillation: a narrative review. Part 2.

Gaurav Panchal, Maria Mahmood, Gregory Y H Lip,

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia with increasing incidence worldwide. Much focus has been directed towards AF prevention, given the morbidity and mortality from stroke, heart failure, and dementia. There are a number of common conditions associated with the onset of AF including, but not limited ... Read more >>

Kardiol Pol (Kardiologia polska)
[2019, 77(5):515-524]

Cited: 0 times

View full text PDF listing >>



Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.

Hai Deng, Alena Shantsila, Yumei Xue, Ying Bai, Pi Guo, Tatjana S Potpara, Xianzhang Zhan, Xianhong Fang, Hongtao Liao, Shulin Wu, Gregory Y H Lip,

INTRODUCTION:Chronic kidney disease (CKD) has been associated with incident atrial fibrillation (AF) and its complications, but data from Asian cohorts are limited. AIM:To explore the relationship of AF recurrence after catheter ablation (CA) with eGFR as a continuous variable, and with different renal function categories (normal: estimated glomerular filtration rate ... Read more >>

Arch Cardiovasc Dis (Archives of cardiovascular diseases)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.

Duncan Wilson, Gareth Ambler, Keon-Joo Lee, Jae-Sung Lim, Masayuki Shiozawa, Masatoshi Koga, Linxin Li, Caroline Lovelock, Hugues Chabriat, Michael Hennerici, Yuen Kwun Wong, Henry Ka Fung Mak, Luis Prats-Sánchez, Alejandro Martínez-Domeño, Shigeru Inamura, Kazuhisa Yoshifuji, Ethem Murat Arsava, Solveig Horstmann, Jan Purrucker, Bonnie Yin Ka Lam, Adrian Wong, Young Dae Kim, Tae-Jin Song, Maarten Schrooten, Robin Lemmens, Sebastian Eppinger, Thomas Gattringer, Ender Uysal, Zeynep Tanriverdi, Natan M Bornstein, Einor Ben Assayag, Hen Hallevi, Jun Tanaka, Hideo Hara, Shelagh B Coutts, Lisa Hert, Alexandros Polymeris, David J Seiffge, Philippe Lyrer, Ale Algra, Jaap Kappelle, Rustam Al-Shahi Salman, Hans R Jäger, Gregory Y H Lip, Heinrich P Mattle, Leonidas D Panos, Jean-Louis Mas, Laurence Legrand, Christopher Karayiannis, Thanh Phan, Sarah Gunkel, Nicolas Christ, Jill Abrigo, Thomas Leung, Winnie Chu, Francesca Chappell, Stephen Makin, Derek Hayden, David J Williams, M Eline Kooi, Dianne H K van Dam-Nolen, Carmen Barbato, Simone Browning, Kim Wiegertjes, Anil M Tuladhar, Noortje Maaijwee, Christine Guevarra, Chathuri Yatawara, Anne-Marie Mendyk, Christine Delmaire, Sebastian Köhler, Robert van Oostenbrugge, Ying Zhou, Chao Xu, Saima Hilal, Bibek Gyanwali, Christopher Chen, Min Lou, Julie Staals, Régis Bordet, Nagaendran Kandiah, Frank-Erik de Leeuw, Robert Simister, Aad van der Lugt, Peter J Kelly, Joanna M Wardlaw, Yannie Soo, Felix Fluri, Velandai Srikanth, David Calvet, Simon Jung, Vincent I H Kwa, Stefan T Engelter, Nils Peters, Eric E Smith, Yusuke Yakushiji, Dilek Necioglu Orken, Franz Fazekas, Vincent Thijs, Ji Hoe Heo, Vincent Mok, Roland Veltkamp, Hakan Ay, Toshio Imaizumi, Beatriz Gomez-Anson, Kui Kai Lau, Eric Jouvent, Peter M Rothwell, Kazunori Toyoda, Hee-Joon Bae, Joan Marti-Fabregas, David J Werring, ,

BACKGROUND:Cerebral microbleeds are a neuroimaging biomarker of stroke risk. A crucial clinical question is whether cerebral microbleeds indicate patients with recent ischaemic stroke or transient ischaemic attack in whom the rate of future intracranial haemorrhage is likely to exceed that of recurrent ischaemic stroke when treated with antithrombotic drugs. We ... Read more >>

Lancet Neurol (The Lancet. Neurology)
[2019, 18(7):653-665]

Cited: 0 times

View full text PDF listing >>



Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients.

Steven Deitelzweig, Allison Keshishian, Xiaoyan Li, Amiee Kang, Amol D Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Xianying Pan, Anagha Nadkarni, Manuela Di Fusco, Alessandra B Garcia Reeves, Huseyin Yuce, Gregory Y H Lip,

OBJECTIVES:Older adult patients are underrepresented in clinical trials comparing non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin. This subgroup analysis of the ARISTOPHANES study used multiple data sources to compare the risk of stroke/systemic embolism (SE) and major bleeding (MB) among very old patients with nonvalvular atrial fibrillation (NVAF) prescribed ... Read more >>

J Am Geriatr Soc (Journal of the American Geriatrics Society)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation.

Yi-Hsin Chan, Hsin-Fu Lee, Lai-Chu See, Hui-Tzu Tu, Tze-Fan Chao, Yung-Hsin Yeh, Lung-Sheng Wu, Chi-Tai Kuo, Shang-Hung Chang, Gregory Y H Lip,

BACKGROUND:Whether four direct oral anticoagulants (DOACs) are superior to warfarin in Asian patients with nonvalvular atrial fibrillation (NVAF) remains unclear. METHODS:This nationwide retrospective cohort study was based on data from Taiwan's National Health Insurance Research Database from June 1, 2012, to December 31, 2017, covering patients with NVAF taking edoxaban ... Read more >>

Chest (Chest)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function.

So-Ryoung Lee, Eue-Keun Choi, Kyung-Do Han, Jin-Hyung Jung, Myung-Jin Cha, Seil Oh, Gregory Y H Lip,

Background and Purpose- In clinical trials, the reduced efficacy of non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention was reported for patients with nonvalvular atrial fibrillation with a creatinine clearance (CrCl) >95 mL/min compared with that of warfarin. We examined the effectiveness, safety, and net clinical benefit of NOACs ... Read more >>

Stroke (Stroke)
[2019, 50(6):1480-1489]

Cited: 0 times

View full text PDF listing >>



Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores.

José Miguel Rivera-Caravaca, Francisco Marín, Juan Antonio Vilchez, Josefa Gálvez, María Asunción Esteve-Pastor, Vicente Vicente, Gregory Y H Lip, Vanessa Roldán,

Background and Purpose- Current European guidelines for the management of atrial fibrillation suggest using biomarkers to refine the risk stratification process. However, it is unclear whether ≥2 biomarkers incrementally improve risk prediction beyond 1 biomarker alone. We investigated whether the predictive performance of CHA2DS2-VASc and HAS-BLED scores could be enhanced ... Read more >>

Stroke (Stroke)
[2019, 50(6):1372-1379]

Cited: 0 times

View full text PDF listing >>



Advertisement

Disclaimer
2.1596 s